Gene expression profiling of synovial sarcoma: Distinct signature of poorly differentiated type

American Journal of Surgical Pathology

Volumn 34, Issue 11, 2010, Pages 1599-1607

  Nakayama, Robert ^a,b   Mitani, Sachiyo ^a   Nakagawa, Takeshi ^a   Hasegawa, Tadashi ^c   Kawai, Akira ^d   Morioka, Hideo ^b   Yabe, Hiroo ^b   Toyama, Yoshiaki ^b   Ogose, Akira ^e   Toguchida, Junya ^f   Nakayama, Tomitaka ^g   Yoshida, Teruhiko ^a   Ichikawa, Hitoshi ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL   (Japan)

^e NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g KYOTO UNIVERSITY   (Japan)

Author keywords

gene expression profiling; poorly differentiated type; synovial sarcoma

Indexed keywords

EID: 78049527531     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181f7ce2c     Document Type: Article

References (29)

1. Allander SV, Illei PB, Chen Y, et al. Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation. Am J Pathol. 2002;161: 1587-1595.
2. Bergh P, Meis-Kindblom JM, Gherlinzoni F, et al. Synovial sarcoma: identification of low and high risk groups. Cancer. 1999;85: 2596-2607.
3. Dardick I, Ramjohn S, Thomas MJ, et al. Synovial sarcoma. Interrelationship of the biphasic and monophasic subtypes. Pathol Res Pract. 1991;187:871-885.
4. Dos Santos NR, de Bruijn DR, van Kessel AG. Molecular mechanisms underlying human synovial sarcoma development. Genes Chromosomes Cancer. 2001;30:1-14.
5. Drewes T, Senkel S, Holewa B, et al. Human hepatocyte nuclear factor 4 isoforms are encoded by distinct and differentially expressed genes. Mol Cell Biol. 1996;16:925-931.
6. Fisher C. Synovial sarcoma: ultrastructural and immunohistochem-ical features of epithelial differentiation in monophasic and biphasic tumors. Hum Pathol. 1986;17:996-1008.
7. Fisher C, de Bruijn DRH, Geurts van Kessel A. Synovial sarcoma. In: Fletcher CD, Unni KK, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Washington, DC, USA: IARC Press; 2002: 200-204.
8. Folpe AL, Schmidt RA, Chapman D, et al. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22:673-682.
9. Guillou L, Benhattar J, Bonichon F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040-4050.
10. Hasegawa T, Yokoyama R, Matsuno Y, et al. Prognostic significance of histologic grade and nuclear expression of beta-catenin in synovial sarcoma. Hum Pathol. 2001;32:257-263.
11. Hemmi K, Ma D, Miura Y, et al. A homeodomain-zinc finger protein, ZFHX4, is expressed in neuronal differentiation manner and suppressed in muscle differentiation manner. Biol Pharm Bull. 2006;29:1830-1835.
12. Kohno Y, Okamoto T, Ishibe T, et al. Expression of claudin7 is tightly associated with epithelial structures in synovial sarcomas and regulated by an Ets family transcription factor, ELF3. J Biol Chem. 2006;281:38941-38950.
13. Kransdorf MJ. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. Am J Roentgenol. 1995;164:129-134.
14. Ladanyi M. Fusions of the SYT and SSX genes in synovial sarcoma. Oncogene. 2001;20:5755-5762.
15. Ladanyi M, Antonescu CR, Leung DH, et al. Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients. Cancer Res. 2002;62:135-140.
16. Lewis JJ, Antonescu CR, Leung DH, et al. Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity. J Clin Oncol. 2000;18: 2087-2094.
17. Machen SK, Easley KA, Goldblum JR. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol. 1999;23:268-275.
18. Masui F, Matsuno Y, Yokoyama R, et al. Synovial sarcoma, histologically mimicking primitive neuroectodermal tumor/Ewing's sarcoma at distant sites. Jpn J Clin Oncol. 1999;29:438-441.
19. Miettinen M, Limon J, Niezabitowski A, et al. Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas. Virchows Arch. 2000;437:275-283.
20. Nakagawa Y, Numoto K, Yoshida A, et al. Chromosomal and genetic imbalances in synovial sarcoma detected by conventional and microarray comparative genomic hybridization. J Cancer Res Clin Oncol. 2006;132:444-450.
21. Nakayama R, Nemoto T, Takahashi H, et al. Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma. Mod Pathol. 2007;20:749-759.
22. Nielsen TO, West RB, Linn SC, et al. Molecular characterisation of soft tissue tumours: a gene expression study. Lancet. 2002;359:1301-1307.
23. Oda Y, Hashimoto H, Tsuneyoshi M, et al. Survival in synovial sarcoma. A multivariate study of prognostic factors with special emphasis on the comparison between early death and long-term survival. Am J Surg Pathol. 1993;17:35-44.
24. Sandberg AA, Bridge JA. Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Synovial sarcoma. Cancer Genet Cytogenet. 2002;133:1-23.
25. Shen J, Scotlandi K, Baldini N, et al. Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities. Oncology. 2000;58:253-260.
26. Szymanska J, Serra M, Skytting B, et al. Genetic imbalances in 67 synovial sarcomas evaluated by comparative genomic hybridization. Genes Chromosomes Cancer. 1998;23:213-219.
27. Taraviras S, Mantamadiotis T, Dong-Si T, et al. Primary structure, chromosomal mapping, expression and transcriptional activity of murine hepatocyte nuclear factor 4gamma. Biochim Biophys Acta. 2000;1490:21-32.
28. Trassard M, Le Doussal V, Hacene K, et al. Prognostic factors in localized primary synovial sarcoma: a multicenter study of 128 adult patients. J Clin Oncol. 2001;19:525-534.
29. Van De Rijn M, Barr FG, Xiong QB, et al. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 1999;23:106-112.